| Abivax SA | 3.96M | US$392M | 10.1% |
| Neurocrine Biosciences, Inc. | 2.5M | US$355M | 9.2% |
| BioMarin Pharmaceutical Inc. | 5.53M | US$332M | 8.6% |
| Arrowhead Pharmaceuticals, Inc. | 4.82M | US$315M | 8.1% |
| Insmed Incorporated | 2.73M | US$311M | 8.0% |
| United Therapeutics Corporation | 475K | US$257M | 6.6% |
| Nurix Therapeutics, Inc. | 7.03M | US$167M | 4.3% |
| Tarsus Pharmaceuticals, Inc. | 2.03M | US$160M | 4.1% |
| Enliven Therapeutics, Inc. | 3.23M | US$148M | 3.8% |
| Disc Medicine, Inc. | 1.64M | US$107M | 2.8% |
| Bicara Therapeutics Inc. | 5.53M | US$103M | 2.7% |
| Dyne Therapeutics, Inc. | 6.2M | US$99.9M | 2.6% |
| Taysha Gene Therapies, Inc. | 18M | US$87.9M | 2.3% |
| Monte Rosa Therapeutics, Inc. | 7.13M | US$85.1M | 2.2% |
| Globus Medical, Inc. | 915K | US$68.5M | 1.8% |
| Crescent Biopharma, Inc. | 3M | US$43.8M | 1.1% |
| Zimmer Biomet Holdings, Inc. | 475K | US$42.2M | 1.1% |
| Travere Therapeutics, Inc. | 600K | US$35.3M | 0.91% |
| Arcus Biosciences, Inc. | 1.3M | US$33.6M | 0.87% |
| Xenon Pharmaceuticals Inc. | 850K | US$31.6M | 0.82% |
| Nektar Therapeutics | 510K | US$30.9M | 0.80% |
| Bright Minds Biosciences Inc. | 545K | US$27.2M | 0.70% |
| BridgeBio Pharma, Inc. | 400K | US$26.3M | 0.68% |
| Immunocore Holdings plc | 850K | US$25.7M | 0.67% |
| Insulet Corporation | 175K | US$22.8M | 0.59% |
| Trevi Therapeutics, Inc. | 1.5M | US$21.4M | 0.55% |
| Sanofi SA | 500K | US$20.6M | 0.53% |
| Savara, Inc. | 3.3M | US$17M | 0.44% |
| SpyGlass Pharma, Inc. | 640K | US$16.6M | 0.43% |
| Zymeworks Inc. | 600K | US$15.9M | 0.41% |
| Cogent Biosciences, Inc. | 475K | US$15.2M | 0.39% |
| Solid Biosciences Inc. | 2.08M | US$15.1M | 0.39% |
| Lexeo Therapeutics, Inc. | 4.32M | US$14.6M | 0.38% |
| Avalo Therapeutics, Inc. | 800K | US$12.3M | 0.32% |
| Zenas BioPharma, Inc. | 395K | US$10.7M | 0.28% |
| Evommune, Inc. | 1.25M | US$10.3M | 0.27% |
| Viking Therapeutics, Inc. | 290K | US$9.45M | 0.24% |
| Stoke Therapeutics, Inc. | 345K | US$8.97M | 0.23% |
| Tectonic Therapeutic, Inc. | 360K | US$8.38M | 0.22% |
| Zura Bio Limited | 1.86M | US$7.74M | 0.20% |
| Glaukos Corporation | 45,000 | US$7.39M | 0.19% |
| Kailera Therapeutics, Inc. | 625K | US$7.14M | 0.18% |
| Anteris Technologies Global Corp. | 850K | US$6.6M | 0.17% |
| Rezolute, Inc. | 1.46M | US$6.02M | 0.16% |
| First Tracks Biotherapeutics, Inc. | 170K | US$6.02M | 0.16% |
| Voyager Therapeutics, Inc. | 2.17M | US$5.8M | 0.15% |
| Maze Therapeutics, Inc. | 175K | US$4.76M | 0.12% |
| Olema Pharmaceuticals, Inc. | 420K | US$3.63M | 0.09% |
| Palisade Bio, Inc. | 2.5M | US$3.38M | 0.09% |
| Neurogene Inc. | 115K | US$3.2M | 0.08% |
| iBio, Inc. | 2.6M | US$3.07M | 0.08% |
| ArriVent BioPharma, Inc. | 100K | US$3.03M | 0.08% |
| OnKure Therapeutics, Inc. | 1.09M | US$2.96M | 0.08% |
| CytomX Therapeutics, Inc. | 535K | US$1.46M | 0.04% |
| Aprea Therapeutics, Inc. | 350K | US$263K | <0.01% |
| Rapport Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Regeneron Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Repligen Corporation | 0 | US$0 | 0.00% |
| Revolution Medicines, Inc. | 0 | US$0 | 0.00% |
| Sagimet Biosciences Inc. - Series A | 0 | US$0 | 0.00% |
| Surrozen, Inc. | 0 | US$0 | 0.00% |
| Tenax Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Abbott Laboratories | 0 | US$0 | 0.00% |
| Alto Neuroscience, Inc. | 0 | US$0 | 0.00% |
| Beta Bionics, Inc. | 0 | US$0 | 0.00% |
| BioCryst Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Bristol-Myers Squibb Company | 0 | US$0 | 0.00% |
| Damora Therapeutics, Inc. | 0 | US$0 | 0.00% |
| GE HealthCare Technologies Inc. | 0 | US$0 | 0.00% |
| Madrigal Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Monopar Therapeutics Inc. | 0 | US$0 | 0.00% |
| Myriad Genetics, Inc. | 0 | US$0 | 0.00% |